β2-adrenergic agonist protects human endothelial cells from hypoxia/reoxygenation injury in vitro

Critical Care Medicine

Volumn 34, Issue 1, 2006, Pages 165-172

  Pottecher, Julien ^b   Cheisson, Gaëlle ^b   Huet, Olivier ^b   Laplace, Christian ^b   Vicaut, Eric ^b   Mazoit, Jean X ^b   Benhamou, Dan ^b   Duranteau, Jacques ^a  

^a BICÊTRE HOSPITAL   (France)

^b NONE

Author keywords

Adrenergic beta agonist; Cell hypoxia; Endothelial cells; Nitric oxide synthase; Reactive oxygen species; Reperfusion injury

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; DICHLOROFLUORESCEIN; FORMOTEROL; PROPIDIUM IODIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ETHANOLAMINE DERIVATIVE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL DEATH; CONTROLLED STUDY; ENDOTHELIUM CELL; EQUILIBRIUM CONSTANT; HOSPITAL CARE; HUMAN; HUMAN CELL; HYPOXIA; MOLECULAR PROBE; OXYGENATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; UMBILICAL VEIN; CELL CULTURE; CELL HYPOXIA; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; IN VITRO STUDY; METABOLISM; PERFUSION; PHYSIOLOGY; REFERENCE VALUE; REPERFUSION INJURY; SENSITIVITY AND SPECIFICITY;

ADRENERGIC BETA-AGONISTS; CELL DEATH; CELL HYPOXIA; CELLS, CULTURED; ENDOTHELIAL CELLS; ETHANOLAMINES; HUMANS; NITRIC OXIDE SYNTHASE; PERFUSION; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; REPERFUSION INJURY; SENSITIVITY AND SPECIFICITY;

EID: 29744447059     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000190618.65836.CF     Document Type: Article

References (41)

1. Salvemini D, Cuzzocrea S: Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med 2002; 33:1173-1185
2. Aird WC: Endothelium as an organ system. Crit Care Med 2004; 32:S271-S279
3. Vallet B: Endothelial cell dysfunction and abnormal tissue perfusion. Crit Care Med 2002; 30:S229-S234
4. Terada LS: Oxidative stress and endothelial activation. Crit Care Med 2002; 30:S186-S191
5. Allen DR, Wallis GL, McCay PB: Catechol adrenergic agents enhance hydroxyl radical generation in xanthine oxidase systems containing ferritin: Implications for ischemia/reperfusion. Arch Biochem Biophys 1994; 315:235-243
6. Newman WH, Castresana MR, Webb JG, et al: Isoproterenol inhibits transcription of cardiac cytokine genes induced by reactive oxygen intermediates. Anesthesiology 2002; 96:947-954
7. Weiss M, Schneider EM, Tarnow J, et al: Is inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via beta-2 adrenoceptors? J Pharmacol Exp Ther 1996; 278:1105-1113
8. Ferro A, Queen LR, Priest RM, et al: Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro. Br J Pharmacol 1999; 126:1872-1880
9. Li C, Jackson RM: Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002; 282:C227-C241
10. Wink DA, Hanbauer I, Krishna MC, et al: Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci U S A 1993; 90:9813-9817
11. Russell JW, Golovoy D, Vincent AM, et al: High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 2002; 16:1738-1748
12. Nishikawa M, Mak JC, Barnes PJ: Effect of short- and long-acting beta 2-adrenoceptor agonists on pulmonary beta 2-adrenoceptor expression in human lung. Eur J Pharmacol 1996; 318:123-129
13. Zink S, Rosen P, Lemoine H: Micro- and macrovascular endothelial cells in beta-adrenergic regulation of transendothelial permeability. Am J Physiol 1995; 269:C1209-C1218
14. Bilski AJ, Halliday SE, Fitzgerald JD, et al: The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol 1983; 5:430-437
15. Brodsky SV, Gao S, Li H, et al: Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am J Physiol Heart Circ Physiol 2002; 283:H2130-H2139
16. Graier WF, Hoebel BG, Paltauf-Doburzynska J, et al: Effects of superoxide anions on endothelial Ca2+ signaling pathways. Arterioscler Thromb Vasc Biol 1998; 18:1470-1479
17. Tas J, Westerneng G: Fundamental aspects of the interaction of propidium diiodide with nuclei acids studied in a model system of polyacrylamide films. J Histochem Cytochem 1981; 29:929-936
18. Vanden Hoek T, Becker LB, Shao ZH, et al: Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res 2000; 86:541-548
19. Zulueta JJ, Sawhney R, Yu FS, et al: Intracellular generation of reactive oxygen species in endothelial cells exposed to anoxia-reoxygenation. Am J Physiol 1997; 272:L897-L902
20. Vanden Hoek TL, Li C, Shao Z, et al: Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 1997; 29:2571-2583
21. Vanden Hoek TL, Becker LB, Shao Z, et al: Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 1998; 273:18092-18098
22. Levraut J, Iwase H, Shao ZH, et al: Cell death during ischemia: relationship to mitochondrial depolarization and ROS generation. Am J Physiol Heart Circ Physiol 2003; 284:H549-H558
23. Patron-Bizet F, Mentre F, Genton M, et al: Assessment of the global two-stage method to EC50 determination. J Pharmacol Toxicol Methods 1998; 39:103-108
24. Communal C, Singh K, Sawyer DB, et al: Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: Role of a pertussis toxin-sensitive G protein. Circulation 1999; 100:2210-2212
25. Kabat A, Ponicke K, Salameh A, et al: Effect of a beta 2-adrenoceptor stimulation on hyperglycemia-induced endothelial dysfunction. J Pharmacol Exp Ther 2004; 308:564-573
26. Conlon PD, Ogunbiyi PO, Black WD, et al: Beta-adrenergic receptor function and oxygen radical production in bovine pulmonary alveolar macrophages. Can J Physiol Pharmacol 1988; 66:1538-1541
27. Gu Y, Seidel A: Influence of salbutamol and isoproterenol on the production of TNF and reactive oxygen species by bovine alveolar macrophages and calcitriol differentiated HL-60 cells. Immunopharmacol Immunotoxicol 1996; 18:115-128
28. Gillissen A, Wickenburg D, van Zwoll D, et al: Beta-2-agonists have antioxidant function in vitro. 2. The effect of beta-2-agonists on oxidant-mediated cytotoxicity and on superoxide anion generated by human polymorphonuclear leukocytes. Respiration 1997; 64:23-28
29. Carden DL, Granger DN: Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000; 190:255-266
30. Clementi E, Brown GC, Foxwell N, et al: On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc Natl Acad Sci U S A 1999; 96:1559-1562
31. Moncada S, Erusalimsky JD: Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat Rev Mol Cell Biol 2002; 3:214-220
32. Agullo L, Garcia-Dorado D, Inserte J, et al: L-arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism. Am J Physiol 1999; 276:H1574-H1580
33. Cristina de Assis M, Cristina Plotkowski M, Fierro IM, et al: Expression of inducible nitric oxide synthase in human umbilical vein endothelial cells during primary culture. Nitric Oxide 2002; 7:254-261
34. Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: Structure, function and inhibition. Biochem J 2001; 357:593-615
35. Yao K, Xu B, Liu YP, et al: Effects of beta-adrenoceptor stimulation on endothelial nitric-oxide synthase phosphorylation of human umbilical vein endothelial cells. Acta Pharmacol Sin 2003; 24:219-224
36. Tan S, Yokoyama Y, Wang Z, et al: Hypoxia-reoxygenation is as damaging as ischemia-reperfusion in the rat liver. Crit Care Med 1998; 26:1089-1095
37. Therade-Matharan S, Laemmel E, Duranteau J, et al: Reoxygenation after hypoxia and glucose depletion causes reactive oxygen species production by mitochondria in HUVEC. Am J Physiol Regul Integr Comp Physiol 2004; 287:R1037-1043
38. Sinaasappel M, van Iterson M, Ince C: Microvascular oxygen pressure in the pig intestine during haemorrhagic shock and resuscitation. J Physiol 1999; 514:245-253
39. Harlan JM, Winn RK: Leukocyte-endothelial interactions: Clinical trials of anti-adhesion therapy. Crit Care Med 2002; 30:S214-S219
40. Nelson HS: Beta-adrenergic bronchodilators. N Engl J Med 1995; 333:499-506
41. Jacinto SM, Chintala MS, Lokhandwala MF, et al: Efficacy and mechanisms of dopexamine in the prevention of ischemia-reperfusion induced organ damage: Role of oxygen free radicals. Clin Exp Hypertens 1997; 19:181-190